Biolase inc.

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the ...

Biolase inc. Things To Know About Biolase inc.

FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering of 14,000,000 shares of its common stock at a price to the public of $1.03 per share, less underwriting discounts and commissions.Jan 20, 2022 · BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse …Payment processing is an ever-evolving field. Here is how NationalLink, Inc. has evolved to provide payment solutions to banks, businesses. Payment processing is an ever-evolving field. And NationalLink, Inc. has evolved with it over the pa...Sep 18, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.

About BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of ...

FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly-designated Series G Preferred Stock, par value $0.001 per share, for each outstanding share of BIOLASE …FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ...

Bovine brucellosis remains a persistent infection in ruminants in Pakistan. A total of 828 (409 buffaloes and 419 cattle) sera were collected from 11 institutional-owned …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…9/30/2023: ANSON FUNDS MANAGEMENT LP Bought 51.3 Thousand shares of BIOLASE Inc: 9/30/2023: BLACKROCK FUND ADVISORS Bought 23.8 Thousand shares of BIOLASE Inc: 9/30/2023: ZHANG FINANCIAL LLC ...Biolase en España, líderes en tecnología dental. Biolase es el líder mundial en el desarrollo y la producción de láseres médicos desde hace más de 25 años!

About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers; products that are focused on …

BIOLASE, Inc. is a biomedical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers.

BIOLASE India Pvt. Ltd. Fun Republic Road, Off New Link Road Andheri (W), Mumbai — 400 053. Tel: +91 22 6195 3400 Shining 3D Tech Co., Ltd. Digital evolution to simplify the workflow in implant dentistry · Dr. Abdelrahman Khalaf Eldabe. Dr. Abdelrahman Khalaf Eldabe.BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems. Our award-winning dental lasers …Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.

FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly-designated Series G Preferred Stock, par value $0.001 per share, for each outstanding share of BIOLASE …Jun 15, 2023 6:30am EDT. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive …Includes Net Income, Adjustments, and Cash flows from investig & financing activities. View Cash Flow. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….The U.S. Food and Drug Administration (FDA) approved Waterlase for the treatment of hard tissue in October 1998, one month before Jeffrey W. Jones was appointed ...Jan 20, 2022 · BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public ...Nov 7, 2023 · LAKE FOREST, Calif., Nov. 7, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ...

Nov 7, 2023 · BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE, Inc. 10 Jan, 2023, 08:00 ET. LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today ...BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR. BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON …The new handpiece uses advanced, proprietary technology to deliver faster healing and quicker recovery for skin-resurfacing patients LAKE FOREST, Calif., Feb. 23, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors …US0909117022. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to ... Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2020, and to answer questions.Dental Laser Procedures & Treatments. BIOLASE award-winning all-tissue and soft-tissue dental lasers are used for minimally invasive procedures and treatments including Endodontics, Periodontics, Dental Implants, Restorative Dentistry, Soft Tissue, and more. Dentists & Laser Dentistry. Hygienists.Annual Reports. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….Feb 27, 2023 · LAKE FOREST, Calif., Feb. 27, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers and a company continually focused on improving the dental ecosystem, has ...

27 jul 2023 ... BIOLASE, Inc. (BIOL) will effect a one-for-one-hundred (1-100) reverse split of its Common Stock. The reverse stock split will become ...

LAKE FOREST, Calif., Sept. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J …

The stock of Biolase Inc (BIOL) has seen a 30.17% increase in the past week, with a -8.48% drop in the past month, and a -63.44% decrease in the past quarter. The volatility ratio for the week is 15.60%, and the volatility levels for the past 30 days are at 10.51% for BIOL. The simple […]BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software.BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all ...Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. BIOLASE Technology, Inc. (BIOLASE), a dental devices company, has promoted its chief financial officer (CFO) David M. Mulder to the company as new chief executive officer (CEO), effective March 5, 2009. Mulder succeeds Jake St. Philip, who has resigned his positions as CEO and director of the company to pursue other interests. …BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants. LAKE FOREST, Calif. , May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an …BIOLASE, Inc. 10 Jan, 2023, 08:00 ET. LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today ...Live Chat Inc. is a tool you can use to interact with customers or clients on the internet. More and more, consumers are demanding and expecting immediate help from the companies they approach. This application enables you to engage with cu...

BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive …LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ...Includes Net Income, Adjustments, and Cash flows from investig & financing activities. View Cash Flow. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all ... Instagram:https://instagram. best mobile bank accountinsider.tmobilehow much is my half dollar wortharm stock forecast BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… best mba bookcummins share price COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted …Oct 27, 2022 · LAKE FOREST, Calif., Oct. 27, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ... top financial advisors in san antonio 9/30/2023: ANSON FUNDS MANAGEMENT LP Bought 51.3 Thousand shares of BIOLASE Inc: 9/30/2023: BLACKROCK FUND ADVISORS Bought 23.8 Thousand shares of BIOLASE Inc: 9/30/2023: ZHANG FINANCIAL LLC ...IRVINE, Calif., Nov. 13, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has entered into a $12.5 million senior secured term loan agreement with SWK Funding LLC. SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a Dallas, Texas-based healthcare focused investment firm.